279 related articles for article (PubMed ID: 26852376)
1. Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?
Ijssennagger N; van der Meer R; van Mil SWC
Trends Mol Med; 2016 Mar; 22(3):190-199. PubMed ID: 26852376
[TBL] [Abstract][Full Text] [Related]
2. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.
Kudelka MR; Stowell SR; Cummings RD; Neish AS
Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):597-617. PubMed ID: 32710014
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide: an agent of stability at the microbiome-mucosa interface.
Wallace JL; Motta JP; Buret AG
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G143-G149. PubMed ID: 29025733
[TBL] [Abstract][Full Text] [Related]
4. Mucus sialylation determines intestinal host-commensal homeostasis.
Yao Y; Kim G; Shafer S; Chen Z; Kubo S; Ji Y; Luo J; Yang W; Perner SP; Kanellopoulou C; Park AY; Jiang P; Li J; Baris S; Aydiner EK; Ertem D; Mulder DJ; Warner N; Griffiths AM; Topf-Olivestone C; Kori M; Werner L; Ouahed J; Field M; Liu C; Schwarz B; Bosio CM; Ganesan S; Song J; Urlaub H; Oellerich T; Malaker SA; Zheng L; Bertozzi CR; Zhang Y; Matthews H; Montgomery W; Shih HY; Jiang J; Jones M; Baras A; Shuldiner A; Gonzaga-Jauregui C; Snapper SB; Muise AM; Shouval DS; Ozen A; Pan KT; Wu C; Lenardo MJ
Cell; 2022 Mar; 185(7):1172-1188.e28. PubMed ID: 35303419
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure.
Nardone OM; de Sire R; Petito V; Testa A; Villani G; Scaldaferri F; Castiglione F
Front Immunol; 2021; 12():694217. PubMed ID: 34326845
[TBL] [Abstract][Full Text] [Related]
6. Tissue metabolism and the inflammatory bowel diseases.
Lanis JM; Kao DJ; Alexeev EE; Colgan SP
J Mol Med (Berl); 2017 Sep; 95(9):905-913. PubMed ID: 28528514
[TBL] [Abstract][Full Text] [Related]
7. Intestinal Inflammation as a Dysbiosis of Energy Procurement: New Insights into an Old Topic.
Lee JS; Wang RX; Alexeev EE; Colgan SP
Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33583319
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen Sulfide Effects on the Survival of Lactobacilli with Emphasis on the Development of Inflammatory Bowel Diseases.
Kushkevych I; Kotrsová V; Dordević D; Buňková L; Vítězová M; Amedei A
Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31756903
[TBL] [Abstract][Full Text] [Related]
9. The gut mucus network: A dynamic liaison between microbes and the immune system.
Inaba R; Vujakovic S; Bergstrom K
Semin Immunol; 2023 Sep; 69():101807. PubMed ID: 37478802
[TBL] [Abstract][Full Text] [Related]
10. Adenosine in Intestinal Epithelial Barrier Function.
Stepanova M; Aherne CM
Cells; 2024 Feb; 13(5):. PubMed ID: 38474346
[TBL] [Abstract][Full Text] [Related]
11. Mucus barrier, mucins and gut microbiota: the expected slimy partners?
Paone P; Cani PD
Gut; 2020 Dec; 69(12):2232-2243. PubMed ID: 32917747
[TBL] [Abstract][Full Text] [Related]
12. Obesity-associated microbiota contributes to mucus layer defects in genetically obese mice.
Schroeder BO; Birchenough GMH; Pradhan M; Nyström EEL; Henricsson M; Hansson GC; Bäckhed F
J Biol Chem; 2020 Nov; 295(46):15712-15726. PubMed ID: 32900852
[TBL] [Abstract][Full Text] [Related]
13. Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics.
Dunleavy KA; Raffals LE; Camilleri M
Dig Dis Sci; 2023 Dec; 68(12):4306-4320. PubMed ID: 37773554
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Metabolic Pathways of Sulfate Reduction in Intestinal Bacteria.
Kushkevych I; Cejnar J; Treml J; Dordević D; Kollar P; Vítězová M
Cells; 2020 Mar; 9(3):. PubMed ID: 32178484
[TBL] [Abstract][Full Text] [Related]
15. Opposing diet, microbiome, and metabolite mechanisms regulate inflammatory bowel disease in a genetically susceptible host.
Pereira GV; Boudaud M; Wolter M; Alexander C; De Sciscio A; Grant ET; Trindade BC; Pudlo NA; Singh S; Campbell A; Shan M; Zhang L; Yang Q; Willieme S; Kim K; Denike-Duval T; Fuentes J; Bleich A; Schmidt TM; Kennedy L; Lyssiotis CA; Chen GY; Eaton KA; Desai MS; Martens EC
Cell Host Microbe; 2024 Apr; 32(4):527-542.e9. PubMed ID: 38513656
[TBL] [Abstract][Full Text] [Related]
16. Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective.
Zhang H; Wu J; Li N; Wu R; Chen W
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188989. PubMed ID: 37742727
[TBL] [Abstract][Full Text] [Related]
17. Mucosa-Mimetic Materials for the Study of Intestinal Homeostasis and Disease.
Donahue R; Sahoo JK; Rudolph S; Chen Y; Kaplan DL
Adv Healthc Mater; 2023 Oct; 12(25):e2300301. PubMed ID: 37329337
[TBL] [Abstract][Full Text] [Related]
18. Reinforcement of the intestinal mucosal barrier via mucus-penetrating PEGylated bacteria.
Chen Y; Lin S; Wang L; Zhang Y; Chen H; Fu Z; Zhang M; Luo H; Liu J
Nat Biomed Eng; 2024 Jun; ():. PubMed ID: 38839928
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen Sulfide as a Toxic Product in the Small-Large Intestine Axis and its Role in IBD Development.
Kushkevych I; Dordević D; Kollar P; Vítězová M; Drago L
J Clin Med; 2019 Jul; 8(7):. PubMed ID: 31330956
[TBL] [Abstract][Full Text] [Related]
20. Biophysical determinants of biofilm formation in the gut.
Arias SL; Brito IL
Curr Opin Biomed Eng; 2021 Jun; 18():. PubMed ID: 34504987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
